General Surgery Experts & Viewpoints
- Why Should I Report an Adverse Drug Event?
- P-4-P? How about P-B4-P?
- CMV Reactivation in ICU Patients; Mobility Protocol for Ventilated Patients
- Can Pharmacists Improve the Accuracy of Medication Histories?
- Recurrence After Groin Hernia Repair -- Does Volume Count?
- What's the Impact of Air Bags After Trauma?
- Retooling for an Aging America
- Topical Negative Pressure Wound Therapy -- Is it Justified?
- Eating Right After Surgery -- Tricky or Treat?
- Should Patients With Colorectal Cancer and Nonresectable Liver Metastasis Have Surgery?
POLL
A new bill in Congress would send trained clinicians into doctors’ offices with independent data about the relative benefits, risks, and costs of drugs; some research suggests that such "academic detailing" reduces potential prescribing bias from the influence of drug company reps. What effect do you think such a program would have?